443 related articles for article (PubMed ID: 31534505)
1. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy.
Thomas E; Menon JU; Owen J; Skaripa-Koukelli I; Wallington S; Gray M; Mannaris C; Kersemans V; Allen D; Kinchesh P; Smart S; Carlisle R; Vallis KA
Theranostics; 2019; 9(19):5595-5609. PubMed ID: 31534505
[TBL] [Abstract][Full Text] [Related]
2. Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation.
Owen J; Thomas E; Menon J; Gray M; Skaripa-Koukelli I; Gill MR; Wallington S; Miller RL; Vallis KA; Carlisle R
J Control Release; 2020 Mar; 319():222-233. PubMed ID: 31891732
[TBL] [Abstract][Full Text] [Related]
3. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
[TBL] [Abstract][Full Text] [Related]
5. Low Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles.
Yu FT; Chen X; Wang J; Qin B; Villanueva FS
Mol Pharm; 2016 Jan; 13(1):55-64. PubMed ID: 26567985
[TBL] [Abstract][Full Text] [Related]
6. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
[TBL] [Abstract][Full Text] [Related]
7. MR-labelled liposomes and focused ultrasound for spatiotemporally controlled drug release in triple negative breast cancers in mice.
Amrahli M; Centelles M; Cressey P; Prusevicius M; Gedroyc W; Xu XY; So PW; Wright M; Thanou M
Nanotheranostics; 2021; 5(2):125-142. PubMed ID: 33457192
[No Abstract] [Full Text] [Related]
8. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
[TBL] [Abstract][Full Text] [Related]
9. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
[TBL] [Abstract][Full Text] [Related]
10. The relationship between surface drug distribution of Dox-loaded microbubbles and drug release/cavitation behaviors with ultrasound.
Lin CW; Fan CH; Yeh CK
Ultrason Sonochem; 2024 Jan; 102():106728. PubMed ID: 38103369
[TBL] [Abstract][Full Text] [Related]
11. Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer.
Ninomiya K; Yamashita T; Kawabata S; Shimizu N
Ultrason Sonochem; 2014 Jul; 21(4):1482-8. PubMed ID: 24418100
[TBL] [Abstract][Full Text] [Related]
12. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.
Goren D; Horowitz AT; Zalipsky S; Woodle MC; Yarden Y; Gabizon A
Br J Cancer; 1996 Dec; 74(11):1749-56. PubMed ID: 8956788
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy.
Dorjsuren B; Chaurasiya B; Ye Z; Liu Y; Li W; Wang C; Shi D; Evans CE; Webster TJ; Shen Y
Int J Nanomedicine; 2020; 15():8201-8215. PubMed ID: 33122906
[TBL] [Abstract][Full Text] [Related]
14. Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells.
Mamot C; Ritschard R; Wicki A; Küng W; Schuller J; Herrmann R; Rochlitz C
J Drug Target; 2012 Jun; 20(5):422-32. PubMed ID: 22519893
[TBL] [Abstract][Full Text] [Related]
15. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
[TBL] [Abstract][Full Text] [Related]
16. Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo.
Zhao YZ; Dai DD; Lu CT; Lv HF; Zhang Y; Li X; Li WF; Wu Y; Jiang L; Li XK; Huang PT; Chen LJ; Lin M
Drug Dev Ind Pharm; 2012 Sep; 38(9):1090-8. PubMed ID: 22188116
[TBL] [Abstract][Full Text] [Related]
17. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.
Cheng L; Huang FZ; Cheng LF; Zhu YQ; Hu Q; Li L; Wei L; Chen DW
Int J Nanomedicine; 2014; 9():921-35. PubMed ID: 24611009
[TBL] [Abstract][Full Text] [Related]
18. Lipid-mimicking peptide decorates erythrocyte membrane for active delivery to engrafted MDA-MB-231 breast tumour.
Fan X; Xu H; Zhao F; Song J; Jin Y; Zhang C; Wu G
Eur J Pharm Biopharm; 2020 Jul; 152():72-84. PubMed ID: 32376370
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
20. The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.
Gao W; Lin Z; Chen M; Yang X; Cui Z; Zhang X; Yuan L; Zhang Q
Int J Nanomedicine; 2014; 9():3425-37. PubMed ID: 25092974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]